Treace Medical Concepts, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TMCI research report →
Companywww.treace.com
Treace Medical Concepts, Inc. , an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement.
- CEO
- John T. Treace
- IPO
- 2021
- Employees
- 477
- HQ
- Ponte Vedra, FL, US
Price Chart
Valuation
- Market Cap
- $182.94M
- P/E
- -2.98
- P/S
- 0.88
- P/B
- 2.36
- EV/EBITDA
- -3.97
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 79.72%
- Op Margin
- -26.89%
- Net Margin
- -29.44%
- ROE
- -69.50%
- ROIC
- -37.26%
Growth & Income
- Revenue
- $212.69M · 1.59%
- Net Income
- $-59,002,000 · -5.85%
- EPS
- $-0.93 · -3.33%
- Op Income
- $-54,154,000
- FCF YoY
- 39.53%
Performance & Tape
- 52W High
- $7.78
- 52W Low
- $1.17
- 50D MA
- $1.76
- 200D MA
- $3.75
- Beta
- 1.11
- Avg Volume
- 858.53K
Get TickerSpark's AI analysis on TMCI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 26 | BAKEWELL JOHN K | other | 30,000 |
| May 19, 26 | Kiernan Jane E | other | 30,000 |
| May 19, 26 | Berry Lance A | other | 30,000 |
| May 19, 26 | Jain Deepti | other | 30,000 |
| May 19, 26 | HAMILTON LAWRENCE W | other | 30,000 |
| May 19, 26 | Hanna Betsy | other | 30,000 |
| May 14, 26 | Treace John T. | buy | 61,750 |
| May 13, 26 | Treace John T. | buy | 49,013 |
| May 12, 26 | Treace John T. | buy | 43,000 |
| Apr 17, 26 | Hair Mark | other | 11,547 |
Our TMCI Coverage
We haven't published any research on TMCI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TMCI Report →